Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04787991
Title Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma (REVOLUTION)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Parker Institute for Cancer Immunotherapy

pancreatic adenocarcinoma


Gemcitabine + Ipilimumab + Nab-paclitaxel + Nivolumab

Gemcitabine + Hydroxychloroquine + Ipilimumab + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.